Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
CMET-47. PRECLINICAL VALIDATION OF NOVEL...
Journal article

CMET-47. PRECLINICAL VALIDATION OF NOVEL THERAPEUTICS TARGETING A BMIC POPULATION IN HUMAN BRAIN METASTASES

Abstract

Abstract Brain Metastases (BM) are the most common neoplasm to affect the adult central nervous system, occurring at a rate 10 times greater than that of primary brain cancers. Despite the prevalence and severe lethality of BM, therapeutic strategies remain limited. Advancements in in vivo modelling of metastasis presents a useful platform to aid in the advance and screening of novel targeting therapeutics, though currently few models exist …

Authors

Singh M; Venugopal C; Tokar T; McFarlane N; Bakhshinyan D; Qazi M; Vora P; Murty N; Jurisica I; Singh S

Journal

Neuro-oncology, Vol. 19, No. Suppl 6, pp. vi49–vi49

Publication Date

November 2017

ISSN

1522-8517

Labels

Fields of Research (FoR)